Total Funding
96
84
Total FundingPost-IPO Debt raised
Growth Score
-3 pts
Heat Score
39 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
2573
Abbott is a healthcare company that produces diagnostic kits, medical devices, nutritional products, and branded generic medicines.
Kathleen Thrush: Section Manager, Clinical Operations- Todd Johnson: Vice PresidentPast Role: Cytovas, President
About the Company
Abbott is engaged in pharmaceuticals and manufacturing healthcare products. It developed the first HIV blood-screening test. Its product portfolio includes Norvir, a treatment for HIV, Synthroid, a synthetic thyroid hormone, Depakote, an anticonvulsant drug, and Humira, a drug for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis
and more.
